Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tongjitang, Guizhou Long-Life Pharmaceuticals Co. Ltd. deal

TCM's Guizhou Tongjitang Pharmaceutical Co. Ltd. subsidiary acquired Guizhou Long-Life for RMB42.2 million ($5.6

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE